|
|
Glaxo to buy Stiefel for up to £2.5 billion (The Malaysian Insider)
LONDON, Apri 20 - GlaxoSmithKline is to buy privately owned Stiefel Laboratories Inc for up to £2.5 billion (RM13 billion) to diversify its business by adding treatments for acne, dermatitis and other skin complaints. The US acquisition is the latest in a string of deals in the drugs sector, but is significantly smaller than recent mega-mergers, reflecting the British-based group's declared ...
Glaxo to buy Stiefel for up to £2.5 billion (Reuters via Yahoo! UK & Ireland News)
GlaxoSmithKline is to buy privately owned Stiefel Laboratories Inc for up to $3.6 billion (2.5 billion pounds) to diversify its business by adding treatments for acne, dermatitis and other skin complaints.
Glaxo to buy Stiefel Labs for up to $3.6 billion (Reuters via Yahoo! News)
GlaxoSmithKline Plc is to buy privately owned Stiefel Laboratories Inc for up to $3.6 billion to diversify its business by adding treatments for acne, dermatitis and other skin complaints.
New Strain Of Acne Is Resistant To Antibiotics (CBS 13 Sacramento)
Eighty-five percent of the teenage population battles acne in some form and in most cases, there will be significant improvement of the outbreak when treated with a combination of medication including antibiotics.
Glaxo buys Stiefel Laboratories for $2.9 billion (AP via Yahoo! News)
British drugmaker GlaxoSmithKline PLC said Monday it will pay $2.9 billion to buy U.S. dermatology business Stiefel Laboratories Inc. ? the latest deal in a flurry of mergers and acquisitions in the pharmaceuticals industry.
Glaxo buys Stiefel Laboratories for $2.9 billion (AP via Yahoo! News)
British drug maker GlaxoSmithKline PLC said Monday it will pay $2.9 billion to buy American dermatology business Stiefel Laboratories Inc. ? the latest deal in a flurry of mergers and acquisitions in the pharmaceuticals industry.
Glaxo Agrees to Buy Stiefel for $2.9 Billion in Cash (Update1) (Bloomberg)
April 20 (Bloomberg) -- GlaxoSmithKline Plc agreed to buy Stiefel Laboratories Inc., a closely held U.S. drugmaker, for $2.9 billion in cash, adding remedies for skin ailments such as acne and diaper rash.
|
Back to Information on Acne
Back to Acne News Arc |
|
|
